- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/015 - Parvoviridae, p. ex. virus de l'aleucémie féline, parvovirus humain
Détention brevets de la classe C07K 14/015
Brevets de cette classe: 548
Historique des publications depuis 10 ans
|
24
|
18
|
45
|
47
|
48
|
35
|
44
|
58
|
59
|
26
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4416 |
18 |
| University of Florida Research Foundation, Inc. | 4179 |
18 |
| The University of North Carolina at Chapel Hill | 2104 |
17 |
| Dyno Therapeutics, Inc. | 62 |
12 |
| The Children's Hospital of Philadelphia | 858 |
11 |
| Genzyme Corporation | 1367 |
9 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3332 |
9 |
| University of Massachusetts | 2317 |
9 |
| The Regents of the University of California | 20778 |
8 |
| Deutsches Krebsforschungszentrum | 397 |
8 |
| Massachusetts Eye and Ear Infirmary | 401 |
8 |
| University of Iowa Research Foundation | 863 |
7 |
| 4D Molecular Therapeutics Inc. | 71 |
7 |
| Packgene Biotech Co., Ltd. | 19 |
7 |
| California Institute of Technology | 4037 |
6 |
| Children's Medical Research Institute | 66 |
6 |
| Genethon | 255 |
6 |
| Medigene AG | 27 |
6 |
| Takara Bio Inc. | 226 |
6 |
| Universite d'Evry Val D'essonne | 218 |
6 |
| Autres propriétaires | 364 |